Ameriprise’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-248,930
| Closed | -$17.9M | – | 3955 |
|
|
2020
Q4 | $17.9M | Buy |
248,930
+17,863
| +8% | +$935K | 0.01% | 1304 |
|
|
2020
Q3 | $10.5M | Buy |
231,067
+3,199
| +1% | +$134K | ﹤0.01% | 1524 |
|
|
2020
Q2 | $10.3M | Sell |
227,868
-3,848
| -2% | -$172K | ﹤0.01% | 1521 |
|
|
2020
Q1 | $8.92M | Sell |
231,716
-7,730
| -3% | -$356K | ﹤0.01% | 1472 |
|
|
2019
Q4 | $11.1M | Sell |
239,446
-3,430
| -1% | -$149K | ﹤0.01% | 1659 |
|
|
2019
Q3 | $9.89M | Sell |
242,876
-26,848
| -10% | -$1.16M | ﹤0.01% | 1693 |
|
|
2019
Q2 | $13M | Buy |
269,724
+61,092
| +29% | +$3.21M | 0.01% | 1522 |
|
|
2019
Q1 | $13.1M | Sell |
208,632
-9,851
| -5% | -$677K | 0.01% | 1472 |
|
|
2018
Q4 | $13M | Sell |
218,483
-76,481
| -26% | -$4.59M | 0.01% | 1381 |
|
|
2018
Q3 | $19M | Buy |
294,964
+1,857
| +0.6% | +$104K | 0.01% | 1346 |
|
|
2018
Q2 | $13.2M | Buy |
293,107
+41,454
| +16% | +$1.65M | 0.01% | 1506 |
|
|
2018
Q1 | $7.81M | Buy |
251,653
+95,388
| +61% | +$3.14M | ﹤0.01% | 1846 |
|
|
2017
Q4 | $4.67M | Sell |
156,265
-88,554
| -36% | -$2.56M | ﹤0.01% | 2190 |
|
|
2017
Q3 | $8.08M | Sell |
244,819
-111,209
| -31% | -$3.85M | ﹤0.01% | 1748 |
|
|
2017
Q2 | $11.9M | Buy |
356,028
+149,379
| +72% | +$4.46M | 0.01% | 1405 |
|
|
2017
Q1 | $5.98M | Buy |
206,649
+3,115
| +2% | +$77.2K | ﹤0.01% | 1900 |
|
|
2016
Q4 | $4.55M | Sell |
203,534
-274
| -0.1% | -$5.36K | ﹤0.01% | 2117 |
|
|
2016
Q3 | $3.78M | Buy |
203,808
+123,681
| +154% | +$2.33M | ﹤0.01% | 2194 |
|
|
2016
Q2 | $1.31M | Buy |
+80,127
| New | +$1.18M | ﹤0.01% | 2752 |
|
|
2014
Q3 | – | Sell |
-30
| Closed | – | – | 6088 |
|
|
2014
Q2 | $0 | Buy |
+30
| New | +$239 | ﹤0.01% | 5877 |
|
|
2013
Q4 | – | Sell |
-98,265
| Closed | -$974K | – | 5828 |
|
|
2013
Q3 | $974K | Buy |
+98,265
| New | +$773K | ﹤0.01% | 2695 |
|
Other funds holding BEAT
Ameriprise's BEAT Position: Q1 2021 in Review
Ameriprise sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 248,930 shares — an estimated $17.9M sold.
Ameriprise first reported a position in BEAT in Q3 2013 and held it in 21 quarters. The position peaked at $19M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Ameriprise reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Ameriprise sold 248,930 BioTelemetry, Inc. shares in Q1 2021, an estimated $17.9M.
- Ameriprise first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 21 quarters.
- Ameriprise's BioTelemetry, Inc. position peaked at $19M in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Ameriprise's 13F filing for Q1 2021, filed 17 May 2021.